Phenytoin-Associated Granulomatous Pulmonary Vasculitis

Area of Science:

• Pulmonary Medicine
• Toxicology
• Rheumatology

Background:

• Phenytoin, an anticonvulsant, has been used since 1938 for seizure disorders.
• While phenytoin-induced allergic reactions and pulmonary disease are documented, pulmonary vascular pathology is rare.
• This highlights the need for awareness of diverse drug-associated lung conditions.

Observation:

• A case report of a 39-year-old African American man with phenytoin use.
• The patient presented with progressive dyspnea and abnormal chest imaging.
• This presentation suggested a potential link to phenytoin medication.

Findings:

• The patient was diagnosed with phenytoin-associated vasculitis.
• This case underscores the infrequent but serious pulmonary vascular complications of phenytoin.
• Vasculitis, a rare adverse effect, can manifest with respiratory symptoms.

Implications:

• Clinicians must consider medication history in patients with unexplained respiratory symptoms.
• Familiarity with drug-induced pneumotoxicity is crucial for accurate diagnosis and management.
• Early identification of phenytoin-associated lung disease can prevent severe complications.